Navigation Links
IntraHealth to Lead $300 Million USAID Project in Global Health Workforce, Systems Strengthening
Date:10/20/2009

CHAPEL HILL, N.C., Oct. 20 /PRNewswire-USNewswire/ -- IntraHealth International has been awarded a new 5-year global cooperative agreement, with a $300 million ceiling, by the United States Agency for International Development (USAID) to improve the quality of health services in the developing world by strengthening the health care workforce. Worldwide, there is a shortfall of 4 million health workers needed to increase access to critical primary health care services, and 57 countries fall short of the World Health Organization's minimum ratio of 2.3 health workers for every 1,000 people.

Under IntraHealth's leadership, the Human Resources for Health and Quality Services (HRHQS) Project will increase the quantity and quality of available health workers and services by working with global organizations and developing country institutions to test and roll out successful workforce planning, retention, recruitment, training and deployment interventions.

The HRHQS Project builds on the foundation established by USAID's investment in the Capacity Project, a 5-year global initiative, also led by IntraHealth, which worked in 47 countries around the globe to strengthen health systems and workforce planning, development and performance support.

"The HRHQS Project will serve as a catalyst at this critical juncture to further advance human resources for health knowledge and practice," says IntraHealth CEO Pape Gaye. "The ultimate goal is a more efficient and effective global health workforce that will reach more people and improve health status and quality of life, especially for the poor and most vulnerable."

The HRHQS Project will be led by Maurice Middleberg, who brings almost 30 years of experience to his new role. Mr. Middleberg joins IntraHealth from the Global Health Council, where he served as Vice President for Public Policy. He has also held positions at USAID, the Futures Group, CARE and EngenderHealth.


'/>"/>
SOURCE IntraHealth International
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. IntraHealth International Addresses Capacity Building and Open Source Technologies at Tech-Themed Global Health Conference
2. IntraHealth to Support Health Reform in Palestine
3. IntraHealths Family Planning Work in Rwanda Contributes to Near Three-Fold Increase in Contraceptive Use in Only Three Years
4. Indiana Home Health Agency Pays Nearly $2 Million to Settle False Claims Act Allegations
5. Karmanos Cancer Institute Receives $3 Million Grant from The Herrick Foundation to Launch Challenge Initiative for Cancer Research
6. Augmenix, Inc. Closes $6.1 Million Financing
7. Mega-Commitment Partners Deworm 20 Million School Age Children in 2009: AIR, Deworm the World, Feed The Children, the World Food Programme Exceed Their CGI Commitment Target in Year One Two-fold
8. Cardium Announces $6.0 Million Registered Direct Offering
9. $4 million NCI grant funds comparative effectiveness research at Southwest Oncology Group
10. Case Western Reserve University receives $20.5 million
11. NIH awards more than $54 Million to Kaiser Permanente to conduct health research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... and environmental concerns about the emerging nanotechnology industry, scientists ... of nanoparticles in municipal sewage treatment plants their ... in ACS, journal Environmental Science & Technology . ... and Hydrology and colleagues note that experts predict large ... than 1/1000th the width of a human hair ...
(Date:12/16/2009)... they cut bleeding time in half, but use in humans ... -- Hoping to improve on nature, researchers have built and ... be used in trauma or other cases where blood just ... with material that is used in degradable stitches, which dissolve ... biomedical engineering at Case Western Reserve University, and lead author ...
(Date:12/16/2009)... for use, expert says, , , WEDNESDAY, Dec. 16 (HealthDay ... less likely to die when they receive an implantable ... included 4,685 people, ages 65 to 85, who were ... fraction (a measure of the heart,s pumping ability) of ... those who were treated with standard medication and an ...
(Date:12/16/2009)... -- Medical travel facilitator Companion Global Healthcare Inc. ... into its network of international hospitals that treat ... at mainland U.S. facilities. ,, The announcement means ... and preferred pricing for its individual clients and ... HIMA San Pablo Bayamon or HIMA San Pablo ...
(Date:12/16/2009)... 16 Quantros, Inc., a leading provider ... solutions for the healthcare industry, announces the creation ... has named software industry veteran Michael Tulloch, MBA, ... work from the company,s new Marlborough, MA office. ... natural one," explains Tulloch. "Quantros has been developing ...
Breaking Medicine News(10 mins):Health News:Behavior modification could ease concerns about nanoparticles 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 3Health News:Implanted Defibrillator Might Extend Life 2Health News:Hospitals in Puerto Rico Join Companion Global Healthcare's Network 2Health News:Safety and Quality Software Developer Quantros, Inc. Launches Healthcare IT Consulting Division 2
... cancer death rate in African Americans has continued to decrease ... in African American men and 18// percent higher in African ... most recent time period (2003). ,However, the ... because rates have decreased faster in African Americans than whites. ...
... has been a marked increase in allergic reactions among people ... a 30 year period.// Teenagers appear to be more susceptible, ... with a trend. ,The common allergic reactions are ... may be required. ,Now researchers are pressing for ...
... exhausted, people should take these complaints seriously// before they ... says a University of Alberta researcher investigating fatigue. ... from the Faculty of Nursing, argues that there are ... those distinctions will help health-care workers create better treatment ...
... clinical practice guidelines for diagnosis and management of venous ... causes clotting in the veins. ,Key elements ... prediction rules to establish pretest probability of deep vein ... testing and the utility of various diagnostic tools such ...
... is a condition resulting from inflammation of joints. ... movement.// ,Spondylarthritis (SpA), ankylosing spondylitis (AS), ... all associated rheumatic diseases collectively known as "spondyloarthropathies".,Aside ... by ankylosis, stiffness and fusion of bone in ...
... vaccines, announced today that it has developed a promising ... Francisella tularensis is a bacterium considered to be one ... ,This vaccine project was funded by a BioDefense ... Institute of Allergy and Infectious Diseases (NIAID), a division ...
Other Medicine News:Health News:Cancer Death Rates High in African-Americans 2Health News:Take Fatigue Seriously - Says Researcher 2Health News:Take Fatigue Seriously - Says Researcher 3Health News:New Guidelines for Diagnosis of Venous Thromboembolism 2Health News:Does Anti-TNF Therapy Control Ankylosis ? 2Health News:Rhode Island Biotechnology Company Develops Tularemia Vaccine 2
(Date:12/16/2009)... 16 BioSpecifics Technologies Corp. (Nasdaq: ... class collagenase-based products, today announced top-line efficacy and ... of XIAFLEX(TM) for the treatment of Peyronie,s disease. ... inelastic collagen on the shaft of the penis, ... intercourse difficult or impossible in advanced cases. The ...
(Date:12/16/2009)... -- Vivakor, Inc. (OTC Bulletin Board: VIVK) ... Baker Consulting out of Walnut Creek, California ... out of South Florida. Baker Consulting ... with business development, financing and assisting the ... Specifically, Baker Consulting is exploring potential acquisition ...
(Date:12/16/2009)... Naurex Inc., a new clinical stage company developing ... based on its novel GFPA NMDA receptor modulators, ... I clinical trial of its lead compound GLYX-13 ... the study. GLYX-13, a glycine site functional ... receptor, is initially being developed as a therapy ...
Breaking Medicine Technology:BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 2BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 3BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 4Vivakor Signs Business Development Agreement With Baker Consulting 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3UPMC and UPMC Health Plan Recognized by National Business Group on Health As a Leading Employer Promoting Healthy Lifestyles for Its Employees 50065 1UPMC and UPMC Health Plan Recognized by National Business Group on Health As a Leading Employer Promoting Healthy Lifestyles for Its Employees 50065 2UPMC and UPMC Health Plan Recognized by National Business Group on Health As a Leading Employer Promoting Healthy Lifestyles for Its Employees 50065 3Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide 12788 1Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide 12788 2Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide 12788 3Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide 12788 4Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide 12788 5Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide 12788 6Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide 12788 7Respiratory Rally a Promising Practice in the Fight Against Chronic Disease 50062 1Respiratory Rally a Promising Practice in the Fight Against Chronic Disease 50062 2
... in brain,research and technology may have a great impact ... scientists visiting the US Senate today. At the,invitation of ... researchers from Posit Science, a leading provider of cognitive,training ... and,part hands-on science fair., "Many believe that we ...
... ... Meeting, WELLESLEY HILLS, Mass., ... of Spherics, Inc. ("Spherics") for,the benefit of creditors, announced today that all ... on October 10,2008., Topamax(R) produces adverse effects on cognitive functions at ...
Other Medicine Technology:Senate Told Brain Technology Can Impact Public Policy 2Senate Told Brain Technology Can Impact Public Policy 3Spherics, Inc. Announces Reduced Cognitive Impairment of Novel Extended Release Topiramate (SRx-502) as Compared to Topamax(R) 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: